MedTrace Logo

Safety and Efficacy Study of Qualia Mind on Cognition in a Healthy Population

NCT04389723 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-10-09

No results posted yet for this study

Summary

This is a randomized, double-blind, placebo-controlled, crossover study designed to investigate the safety and efficacy of Qualia Mind on cognition in a healthy adult population between ages of 18 and 75 years. Qualia Mind is a nootropic supplement containing a complex mixture of vitamins, minerals, amino acids, choline donors, and herbal ingredients. These components have been demonstrated to exert their cognitive effects through distinct mechanisms of action involving cholinergic, glutamatergic, and dopaminergic receptor signalling; neuroplasticity; and modulation of cell membrane structure and metabolism.

Conditions

  • Healthy
  • Cognitive Function

Interventions

DIETARY_SUPPLEMENT

Qualia Mind

Multi-ingredient Dietary supplement

DIETARY_SUPPLEMENT

Placebo

Multi-ingredient Placebo

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Neurohacker Collective

    lead INDUSTRY

Principal Investigators

  • Rupal Trivedi, MD · Great Lakes Clinical Trials LLC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-12
Primary Completion
2020-09-15
Completion
2020-09-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04389723 on ClinicalTrials.gov